Press release
Electronic Data Exchange in Bavarian Medical Network: Patient-Partner Association uses Web-Based Health Record LifeSensor
The Patient-Partner Association (PPV) and the German statutory health insurance AOK Bavaria have concluded a novel, GP-based agreement on integrated care, which for the first time requires electronic communication between the participating physicians and patients. The physicians' network with over 300 linked medical experts uses the Internet-based health record LifeSensor by the German eHealth company InterComponentWare AG (ICW) for this purpose.In the online health record LifeSensor, the attending PPV physicians have access to the copies of their patient's health data provided by other physicians of the association. This data includes diagnoses, medications, allergies, vaccinations as well as check-up and lab results. As the "owner" of the online record, the patient decides which physicians may access his data, change or delete it. Patients who cannot or do not want to grant these authorizations themselves can ask their physician, pharmacist or another representative to assign these access authorizations. This method has proven itself due to the high degree of trust the patients place in the PPV physicians.
Dr. Elmar Schmid, initiator of the PPV: "With the personal health record LifeSensor, the linked GPs and medical specialists can access extensive patient information for the first time in a joint online database. Pharmacists, physiotherapists and nursing staff can also access certain information in the record, which they are authorized to view. We are thus already using essential advantages of digital communication between health service providers and patients in the Patient-Partner Association today, which are so far first scheduled nationwide for the second expansion stage of the electronic health card."
The fast information exchange also facilitates the establishment of special medical offices: some general practitioners in the PPV concentrate on the treatment of relatively rare diseases like chronic lesions or severe cardiac insufficiency. Other physicians in the association then refer their patients with these rare diseases to the specialists. These document their treatment in a special protocol in the personal health record LifeSensor so that the GP is always informed about the latest therapy status. The higher case rate and the associated specialization could contribute to significant improvements in the care quality for rare diseases and prevent unnecessary inpatient stays. PPV physicians can compile an individual care team for patients requiring ambulant care, which may for example consist of an ambulant nurse and a physiotherapist or an ergotherapist. The conversations with the care team are documented in a case protocol in the health record. Afterwards, the care services can set up a current care protocol in the health record based on their patient visits, which the attending physician can access.
Besides better and faster care, patients insured with AOK who conclude the novel agreement on integrated care have additional advantages thanks to the optimized communication between the participating physicians: they can use the personal health record LifeSensor free of charge and also only have to pay the medical registration fee of 10 € once a year. In addition, they are entitled to an extensive health check once a year free of charge.
For more information please contact:
InterComponentWare AG
Dirk Schuhmann
Public Relations
Otto-Hahn-Strasse 3
69190 Walldorf
Tel. ++49-6227-385-133
dirk.schuhmann@icw-global.com
About InterComponentWare
InterComponentWare AG (ICW) is a leading international eHealth provider with locations in Germany, Austria, the USA and Bulgaria. It develops and markets components for networking the different players in the health care industry, among them the hardware connector Medical NTBA and the patient-focused personal health record LifeSensor, the technology leader in this field. As part of the German government-consulting consortium bIT4health, ICW has rendered important consulting services for the introduction of the electronic health card in Germany and is additionally involved in the Austrian eCard project. With its cooperation in national and international steering and work groups for the establishment of an eHealth infrastructure, ICW promotes the standardization aims in the health care industry.
About the Patient-Partner Association (PPV)
The Patient-Partner Association (PPV) is a strongly expanding fusion of presently 343 physicians in all disciplines, nine pharmacies, four medical care services and three rehabilitation institutes in Bavaria. It wants to offer its patients integrated, quality-oriented care and create more transparency through the application of the Internet-based personal health record LifeSensor for medical staff and patients. The organization is organized by GMZ GmbH, which also concluded the agreement with the AOK Bavaria.
The PPV is open to further physicians, pharmacists and other health service providers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Electronic Data Exchange in Bavarian Medical Network: Patient-Partner Association uses Web-Based Health Record LifeSensor here
News-ID: 358 • Views: …
More Releases from InterComponentWare AG

ICW makes a substantial strategic commitment to focus on the U.S. market
Bala Cynwyd, PA, November 17, 2014
InterComponentWare AG (ICW), an international eHealth company headquartered in Walldorf, Germany, has invested substantially over the last two years to strongly focus on the current and future needs of the U.S. healthcare market, especially in the areas of Care Coordination and Care Management. Based on its mature, best-of-breed Health Information Exchange (HIE) and Master Patient Index (MPI) solutions, ICW has developed care management applications supporting…
ICW Master Patient Index Successful with IHE Testing and HITSP
Wayne, PA, March 18, 2009 – eHealth specialist InterComponentWare (ICW) has successfully demonstrated its technological leadership in healthcare IT connectivity at the IHE North American Connectathon, the only large-scale interoperability testing event for the healthcare industry. For three years in a row, the interoperability of ICW's Master Patient Index (ICW MPI) has been designated as IHE conformant. The interoperability of the ICW MPI suc-ceeded in over 65 tests…
Bulgaria opts for eHealth technology "made by ICW"
Sofia/Bulgaria, March 4, 2009 – Bulgarian Minister of Health Dr. Evgenii Zhelev, MD and Minister for State Administration and Administrative Reform Nikolay Vassilev today issued the country's first personal health records. The "Electronic Personal Ambulatory Book" was developed by eHealth specialist InterComponentWare (ICW) and Kontrax, a Bulgarian provider for medical practice management systems. The new solution will serve the same function as the paper-based personal ambulatory books of 40,000 state…
Family Physician-Centered Health Care in Baden Württemberg to Become Easier
Improved Data Sharing Between Hausarzt+ and PMS Software
Walldorf/Stuttgart, January 29, 2009 - In the run up to MEDIZIN 2009 four suppliers of physician practice management systems and InterComponentWare (ICW) announced that data sharing between their systems and Hausarzt+, an add-on software for the family-physician medical care contract in Baden-Württemberg, has been made ever more quick and easy. The releases for the second quarter of 2009 are already being delivered with…
More Releases for PPV
Global Megastar Burna Boy To Headline Revolutionary PPV Event, Powered By The Ce …
London, England - In a groundbreaking fusion of music and technology, Grammy Award-winning sensation Burna Boy will headline the launch of a new hybrid concert series in March 2026. This landmark event marks the first in a series of high-profile live pay-per-view performances planned by Centili Group for its new streaming service, partnered with revolutionary Metaverse company Sansar, and African media partner NEXT Digital.
The event will feature a unique multi-platform…
Post Polycythemia Vera Myelofibrosis (PPV-MF) Market: Emerging Trends and Growth …
The Post Polycythemia Vera Myelofibrosis (PPV-MF) Market is projected to reach approximately USD 3.1 billion by 2033, growing at a CAGR of around 7.2% during the forecast period from 2024 to 2033.
Post Polycythemia Vera Myelofibrosis (PPV-MF) Market Overview
The PPV-MF market is gaining momentum as awareness of rare hematologic conditions grows and diagnostic capabilities advance globally. This disorder, a progression from polycythemia vera, presents significant therapeutic challenges, driving demand for targeted…
Emerging Porcine Epidemic Diarrhea Vaccines Market Trend 2025-2034: Innovative P …
How Is the Porcine Epidemic Diarrhea Vaccines Market Projected to Grow, and What Is Its Market Size?
In recent times, the market size for porcine epidemic diarrhea vaccines has seen significant growth. The size of the market is forecasted to increase from $1.67 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. This growth during the historic period can be credited to factors…
Post Polycythemia Vera Myelofibrosis (PPV-MF) Market to Witness Robust Expansion …
Post Polycythemia Vera Myelofibrosis (PPV-MF) Market is expected to grow at a significant CAGR of 9.1% during the forecast period. The main factors that drive the PPV MF market are due to increasing incidence rates and a rise in awareness among the masses about PPV-MF diagnosis, increasing demand for newer treatment options with better efficacy and safety profile, and growing adoption of immunotherapy across various countries globally. Post Polycythemia Vera Myelofibrosis…
Insights on the Post Polycythemia Vera Myelofibrosis (PPV-MF) Market to 2027 | I …
The global post polycythemia vera myelofibrosis (PPV-MF) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Post-polycythemia vera myelofibrosis is a form of the myeloproliferative neoplasm and is also called chronic idiopathic myelofibrosis. It is a rare chronic blood cancer. People with myelofibrosis (MF) have a defect in their bone marrow that results in an abnormal production of blood cells which causes scar tissue to…
Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Polycythemia Vera Myelofibrosis (PPV-MF) – Pipeline Review, H1 2017, provides an overview of the Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology) pipeline landscape.
Post-Polycythemia Vera Myelofibrosis (PPV-MF) is a myeloproliferative blood cancer in which the bone…